| 摘要 |
<p>The present invention is directed to novel pharmaceutical compositions of the compound 2- (R)- (1- (R)- (3, 5-bis (trifluoromethyl) phenyl)ethoxy)- 3-(S)- 4-fluoro) phenyl-4- (3-(5-oxo- 1H, 4H-1, 2, 4-triazolo) methylmorpholine. The pharmaceutical compositions of this invention useful in the treatment or prevention of disorders such as psychiatric disorders including depression and anxiety, inflammatory diseases and emesis.</p> |
